Replies to post #12846 on Inovio Pharmaceuticals Inc (INO)

[KingDMC]

Inovio Pharmaceuticals (NASDAQ:INO): Q4 EPS of -$0.12 misses by $0.02.
Revenue of $2.5M (+43.7% Y/Y) misses by $2.74M.